Coronary artery bypass graft (CABG) is one of the methods
used in removing plaque or occlusions caused by arterosclerosis or
atherosclerosis. It unclogs the coronary arteries and restores natural blood
flow within the heart. It is also known as coronary artery bypass surgery. The
increasing cases of cardiovascular disorders (CVD) among the geriatric populace
have triggered the need of CABG globally.
Almost 75% of sudden cardiac arrest incidences are treated
with CABG. It has a higher approval rating than percutaneous coronary
intervention (PCI) or coronary stents. The advent of less invasive techniques
within CABG such as endoscopic computer (robotics)-assisted CABG (C-CAB), full-sternotomy
“off-pump” CABG (OPCAB), and minimally-invasive direct CABG (MIDCAB) are
reducing the mortality rates. OPCAB had a 60% approval rate out of all these
methods in Japan and China.
View Summery OF These Report Click Here
Latest Trends
MAQUET Holdings recently launched the HEARTSTRING III
Proximal Seal System to perform CABG without relying on occlusion clamps. This
makes it easier to perform saphenous vein conduits. It even reduces
complications in coronary artery bypass surgery and increases the life of the
patient.
Technology is playing a vital role with the advent of Robotic
assisted CABG. Cardiac surgeons at the Wisconsin Heart Hospital have completed
off-pump surgeries using the da Vinci(R) Surgical System. This has resulted in
shorter surgery durations and higher patient outcome levels.
Market Overview
The worldwide coronary bypass graft (CABG) market is
estimated to reach USD 128 million by 2025, according to Grand View Research,
Inc. It is expected to proliferate at a CAGR close to 6% over the forecast
period (2014 - 2025). It is driven by technologically advanced products like Anastomosis
Assist Devices (AAD) and the growing geriatric populace susceptible
cardiovascular disorders (CVDs).
Saphenous vein graft surgery is expected to dominate the
global market throughout the forecast period. Off-pump CABG is anticipated to
gain market shares in the forthcoming years on account of new minimally
invasive techniques. North America is expected to lead the market over the
forecast period due to rising cases of CVDs and key demographics residing in
the region. Prominent market players include Medtronic, Terumo Corporation, KARL
STORZ GmbH & Co. KG, and Vitalitec.
ConversionConversion EmoticonEmoticon